Please ensure Javascript is enabled for purposes of website accessibility

Why Teladoc Health Stock Sank 18% Last Month

By Jeremy Bowman - Apr 2, 2021 at 4:16PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Shares of the telehealth company fell on a broader sell-off in growth stocks and as Amazon made further headway into the industry.

What happened

Shares of Teladoc Health (TDOC 1.65%) were moving lower last month as investors continued to sell high-priced growth stocks that have been pandemic winners. Teladoc, which saw demand for its telehealth services surge during the pandemic, clearly fits into that category. Rising interest rates also pushed investors growth stocks into value stocks and recovery plays.

The only significant piece of news that affected the stock was that Amazon (AMZN 0.45%) said it was expanding its Amazon Care telehealth service across the country this summer, which is seen as a threat to Teladoc. According to data from S&P Global Market Intelligence, the stock finished March down 17%.   

A mother and child teleconference with a doctor.

Image source: Teladoc.

The chart below shows its trajectory. 

TDOC Chart

TDOC data by YCharts

So what

Shares of Teladoc plunged in the first week of March along with a broad sell-off in growth stocks as investors responded to expectations of an accelerated reopening schedule and rising interest rates. These in turn incentivize rotating out of growth stocks as discount rates rise and investors see long-dated earnings as less valuable.

Teladoc shares remained volatile over the duration of the month even as the Nasdaq recovered its losses, a sign that pressure remains on the stock. 

On March 17, Amazon said that its Amazon Care service would expand nationwide, offering millions of individuals and families access to remote healthcare 24 hours a day, 365 days a year. The company also said it would expand its in-person clinics in cities like Washington DC, Baltimore, and others, showing it's making a major play in the healthcare sector.

Teladoc sold off on the news, though a number of analysts said that the response was overdone and that Amazon's expansion was expected.  

Now what

Teladoc is widely considered the leader in the telehealth sector as the company has grown both organically and through acquisitions, like its takeover of Livongo Health last year. However, competition is likely to heat up in the space, especially as the pandemic has accelerated demand for telehealth services. 

Investors should expect continued volatility from the stock since Teladoc is growing quickly but is still unprofitable and faces a lot of uncertainty as the telehealth industry evolves.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Teladoc Health, Inc. Stock Quote
Teladoc Health, Inc.
$33.28 (1.65%) $0.54, Inc. Stock Quote, Inc.
$2,161.54 (0.45%) $9.72

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/23/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.